Document Detail


Early PET/CT after radiofrequency ablation in colorectal cancer liver metastases: is it useful?
MedLine Citation:
PMID:  20819630     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Morphologic imaging after radiofrequency ablation (RFA) of liver metastases is hampered by an inflammatory response in the ablation margin, making the identification of local tumor progression (LTP) difficult. The aim of this study was to evaluate the efficacy of early (18)F-FDG PET/CT scanning to monitor the effectiveness of RFA in colorectal liver metastases.
METHODS: Twelve patients with 20 metastases were treated with RFA for colorectal liver metastases. They underwent PET/CT within 2 weeks before RFA and within 24 hours after RFA (so termed "early PET/CT"). PET/CT was repeated at 1, 3, and 6 months, and then every 6 months after ablation. The standard of reference was based on available clinical and radiological follow-up data.
RESULTS: Early PET/CT revealed total photopenia in 16 RFA-treated metastases, which were found to be without residual tumor on the final PET/CT scan. Three RFA-treated metastases with focal uptake were identified as local tumor progression, which necessitated further treatment. One RFA-treated metastasis with rim-shaped uptake was regarded as inflammation. The results of the early PET/CT scanning were consistent with the findings of the final follow-up.
CONCLUSIONS: PET/CT performed within 24 hours after RFA can effectively detect whether residual tumor exists for colorectal cancer liver metastases. The results can guide further treatment, and may improve the efficacy of RFA.
Authors:
Zhao-Yu Liu; Zhi-Hui Chang; Zai-Ming Lu; Qi-Yong Guo
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Chinese medical journal     Volume:  123     ISSN:  0366-6999     ISO Abbreviation:  Chin. Med. J.     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-09-07     Completed Date:  2010-12-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7513795     Medline TA:  Chin Med J (Engl)     Country:  China    
Other Details:
Languages:  eng     Pagination:  1690-4     Citation Subset:  IM    
Affiliation:
Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China. liuzy@sj-hospital.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Catheter Ablation*
Colorectal Neoplasms / complications*,  radiography,  radionuclide imaging,  therapy*
Female
Fluorodeoxyglucose F18 / therapeutic use
Humans
Liver Neoplasms / radiography,  radionuclide imaging,  secondary*,  therapy*
Male
Middle Aged
Positron-Emission Tomography / methods*
Tomography, X-Ray Computed / methods*
Chemical
Reg. No./Substance:
63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Influence of drug treatment on glucocorticoid receptor levels in patients with coronary heart diseas...
Next Document:  A small-dose naloxone infusion alleviates nausea and sedation without impacting analgesia via intrav...